SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?


To: zurdo who wrote (4077)7/9/1998 12:31:00 PM
From: Anthony Wong  Read Replies (3) | Respond to of 9523
 
Pfizer Inc. Maintained 'Buy' at Warburg Dillon Read

Bloomberg News
July 9, 1998, 10:23 a.m. ET

Princeton, New Jersey, July 9 (Bloomberg Data) -- Pfizer Inc. (PFE US)
was maintained ''buy'' by analyst Jerome R. Brimeyer at Warburg Dillon Read
Inc.. The 12-month target price is $135.00 per share.

-- Andrew Bekoff in Princeton, New Jersey, (609)279-3652



To: zurdo who wrote (4077)7/9/1998 2:02:00 PM
From: B.REVERE  Read Replies (2) | Respond to of 9523
 
BROKE THROUGH 115 @ 2 P.M AS 300,000 shares traded in 2 minutes.
Let's see it hold from here.

Later,